Molecular Genetics of Fletcher and Fitzgerald Traits

Introduction: Deficiencies of the plasma protease zymogen prekallikrein (PK) and its substrate, high molecular weight kininogen (HK), were discovered in 1965 and 1975, respectively [1] [2]. Initially, they were referred to as Fletcher and Fitzgerald traits after the first patients identified [1] [2]. Shortly thereafter, other deficient subjects were discovered, such as Williams and Reid [3] [4]. Williams trait is a kininogen null plasma, whereas Fitzgerald trait contains low molecular weight kininogen but no HK coagulant activity. In 2003, Fitzgerald trait was found to have a small HK, missing domain 6 [6]. Its DNA was sequenced, and a deep intronic insertion/deletion of unknown significance in intron 9 of KNG1 was hypothesized to be causative by Krijanovski et al. [6].

Method: Due to technical progress and new scientific insights, we were now able to sequence and reevaluate cell-free DNA from these historic plasma samples using pyro- and next generation sequencing techniques.

Results: As a control, Williams plasma was confirmed to carry the homozygous KNG1 variant c.586C>T, p.Arg196 * [5]. Fletcher trait was found to be KLKB1 c.451dupT (rs560588447), the most prevalent African variant, leading to PK deficiency. Fitzgerald and Reid traits were found to have the same variant, c.1609_1610delCA p.Gln537Aspfs*25 (rs758429575), in KNG1s exon 10. This variant likewise only occurs in people of African descent, which is consistent with Reid’s and Fitzgerald’s reported ancestry. On immunoblots, Fitzgerald and Reid plasmas show a small HK with antibodies to HK’s domain 5, but none with antibodies to domain 6. Therefore, a functionality of the intronic variant discovered by Krijanovski et al. [6] can be ruled out and the present frameshift mutation is solely responsible for the residual HK seen in Fitzgerald trait.

Conclusion: Thus, the first cases of PK and HK deficiency discovered have now been genetically clarified. They confirm that no missense mutations are currently known to cause HK deficiency. Further, they emphasize the comparatively increased prevalence of PK and HK deficiency in sub-Saharan Africans. This finding suggests that widespread diseases such as malaria may have influenced the progression of these mutations in this population.

Publikationsverlauf

Artikel online veröffentlicht:
13. Februar 2025

• References

• 1 Hathaway WE, Belhasen LP, Hathaway HS. 1965; ’Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties.’. Blood 26 (05) 521-532
• 2 Saito H, Ratnoff OD, Waldmann R, Abraham JP.. 1975; ‘Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil).’. J Clin Invest 55 (05) 1082-1089
• 3 Colman RW, Bagdasarian A, Talamo RC. et al. 1975; ‘Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.’. J Clin Invest 56 (06) 1650-1662
• 4 Lutcher C.. 1976 ‘Reid trait: a new expression of high molecular weight kininogen (HMW-Kininogen) deficiency.’. Clin Res. 24 440A
• 5 Cheung PP, Kunapuli SP, Scott CF, Wachtfogel YT, Colman RW. 1993; ‘Genetic basis of total kininogen deficiency in Williams' trait.’. J Biol Chem 268 (31) 23361-23365
• 6 Krijanovski Y, Proulle V, Mahdi F, Dreyfus M, Müller-Esterl W, Schmaier AH.. 2003; ‘Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression’. Blood 101 (11) 4430-4436